With biosims closing in, Amgen CEO Bradway scored 10% raise to $18.6M in 2018

Even as Amgen faces a likely sales decline in 2019, its chief executive earned a 10% raise in 2018, his first since 2015. Robert Bradway's pay came in at $18.56 million last year, ranking among biopharma's largest.